Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4/A Shares withheld for taxes Chief Business Officer gave up 10,686 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 4,984 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
  4. 4/A Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
  5. 4 Shares withheld for taxes CEO gave up 9,952 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Business Officer gave up 40,165 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 26,645 shares (to pay taxes)
  8. 4 Option exercise President and COO acquired 26,750 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Option exercise Director acquired 4,793 shares (option exercise)
  12. 4 Option exercise Director acquired 4,793 shares (option exercise)
  13. 4 Option exercise Director acquired 4,793 shares (option exercise)
  14. 4 Option exercise Director acquired 4,793 shares (option exercise)
  15. 4 Option exercise Director acquired 4,793 shares (option exercise)
  16. 4 Option exercise Director acquired 4,793 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Shares withheld for taxes CEO gave up 2,975 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO gave up 3,042 shares (to pay taxes)

Page 2 of 21 · 414 filings